S
Savas Tasoglu
Researcher at Koç University
Publications - 132
Citations - 5349
Savas Tasoglu is an academic researcher from Koç University. The author has contributed to research in topics: Medicine & Computer science. The author has an hindex of 36, co-authored 100 publications receiving 4001 citations. Previous affiliations of Savas Tasoglu include University of Connecticut & Boğaziçi University.
Papers
More filters
Journal ArticleDOI
Bioprinting for stem cell research
TL;DR: Recent achievements with bioprinting technologies in stem cell research are reviewed, and future challenges and potential applications including tissue engineering and regenerative medicine, wound healing, and genomics are identified.
Journal ArticleDOI
Bioprinting for cancer research
TL;DR: 3D cancer models that mimic the tumor microenvironment are discussed, providing a platform for deeper understanding of cancer pathology, anticancer drug screening, and cancer treatment development.
Journal ArticleDOI
Untethered micro-robotic coding of three-dimensional material composition
TL;DR: This work describes a method to code complex materials in three-dimensions with tunable structural, morphological, and chemical features using an untethered magnetic micro-robot remotely controlled by magnetic fields, and demonstrates the coding of soft hydrogels, rigid copper bars, polystyrene beads, and silicon chiplets into three-dimensional heterogeneous structures.
Journal ArticleDOI
3D-printed microfluidic devices.
Reza Amin,Stephanie Knowlton,Alexander Hart,Bekir Yenilmez,Fariba Ghaderinezhad,Sara Katebifar,Michael Messina,Ali Khademhosseini,Ali Khademhosseini,Ali Khademhosseini,Savas Tasoglu +10 more
TL;DR: A broad range of approaches for the application of 3D printing technology to fabrication of micro-scale lab-on-a-chip devices are discussed, making microfluidics more accessible to users.
Journal ArticleDOI
Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules
Imran Rizvi,Umut A. Gurkan,Savas Tasoglu,Nermina Alagic,Jonathan P. Celli,Jonathan P. Celli,Lawrence B. Mensah,Zhiming Mai,Utkan Demirci,Utkan Demirci,Tayyaba Hasan,Tayyaba Hasan +11 more
TL;DR: It is demonstrated that fluidic streams induce a motile and aggressive tumor phenotype, and the microfluidic platform developed here potentially provides a flow-informed framework complementary to conventional mechanism-based therapeutic strategies, with broad applicability to other lethal malignancies.